Literature DB >> 17893206

Psychiatric use and utility of divalproex sodium in Connecticut prisons.

Jayesh Kamath1, Humberto D Temporini, Susan Quarti, Karen L Pagano, Nicholas Demartinis, Robert L Trestman.   

Abstract

Divalproex sodium (DVX) is used in correctional settings to treat impulsive aggression and mood lability in patients without comorbid bipolar disorder. This review of DVX use in the Connecticut Department of Correction examined the psychiatric diagnostic impression of patients prescribed DVX, the doses used, and the symptomatic and functional change over time. Clinical charts of 168 offenders treated with DVX for one or more months were randomly selected for clinical outcome review and were divided into subgroups based on clinical impression for DVX prescription. In participants without bipolar disorder (44.6%), DVX was used to target impulsivity (14.3%) and mood lability (17.3%). Clinical improvement was noted in bipolar and nonbipolar groups (p < .001). The impulsive/aggressive subgroup was the only nonbipolar subgroup in which DVX yielded clinical benefit. This symptom-driven use of DVX is associated with clinical improvement when impulsive aggression is the target symptom.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17893206     DOI: 10.1177/0306624X07307367

Source DB:  PubMed          Journal:  Int J Offender Ther Comp Criminol        ISSN: 0306-624X


  2 in total

1.  Approved and Off-Label Use of Prescribed Psychotropic Medications among Federal Canadian Inmates.

Authors:  Gregory P Brown; Lynn A Stewart; Terry Rabinowitz; Harold Boudreau; Angela J Wright
Journal:  Can J Psychiatry       Date:  2018-04-29       Impact factor: 4.356

Review 2.  Pharmacological Approaches to Managing Violence and Aggression in Prison Populations: Clinical and Ethical Issues.

Authors:  Michael Weightman; Ranjit Kini; Robert Parker; Mrigendra Das
Journal:  Drugs       Date:  2020-11       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.